Literature DB >> 11867583

Impaired vertical phoria adaptation in patients with cerebellar dysfunction.

Reika Kono1, Satoshi Hasebe, Hiroshi Ohtsuki, Kennichi Kashihara, Yoshihiko Shiro.   

Abstract

PURPOSE: To determine whether phoria adaptation to a vertical prism disparity is altered in patients with cerebellar dysfunction.
METHODS: With a computer-aided haploscope, adaptive responses of fusion-free eye position to a 10- or 30-minute period was measured in subjects wearing a 3-prism diopter vertical prism over one eye. Thirteen patients with well-documented cerebellar diseases who did not have manifest ocular misalignment or limited versional eye movement and age-matched healthy subjects participated.
RESULTS: The mean +/- SD percentage of vertical phoria adaptation was 13% +/- 22% and 20% +/- 16% for the 10- and 30-minute adaptations, respectively. These levels were significantly smaller than the respective ones in the age-matched control group (P < 0.001, repeated measures MANOVA). Seven (54%) of 13 patients, including two with genetically confirmed pure cerebellar lesions (spinocerebellar ataxia type 6), showed markedly reduced responses to both the 10- and 30-minute adaptations. In all three patients with acute cerebellar ataxia, the adaptive response was improved at the same time as remission of cerebellum-associated neurologic deficits.
CONCLUSIONS: Phoria adaptation to vertical binocular disparity is frequently impaired in patients with cerebellar dysfunction. These results bolster the hypothesis that phoria adaptation is a cerebellar-dependent response.

Entities:  

Mesh:

Year:  2002        PMID: 11867583

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  Eye Movement Research in the Twenty-First Century-a Window to the Brain, Mind, and More.

Authors:  Aasef G Shaikh; David S Zee
Journal:  Cerebellum       Date:  2018-06       Impact factor: 3.847

2.  Integration of proprioceptive signals and attentional capacity during postural control are impaired but subject to improvement in dyslexic children.

Authors:  Patrick Quercia; Laurent Demougeot; Mickaël Dos Santos; François Bonnetblanc
Journal:  Exp Brain Res       Date:  2011-02-26       Impact factor: 1.972

3.  Esophoria or esotropia in adulthood: a sign of cerebellar dysfunction?

Authors:  Katharina Hüfner; Claudia Frenzel; Olympia Kremmyda; Christine Adrion; Stanislavs Bardins; Stefan Glasauer; Thomas Brandt; Michael Strupp
Journal:  J Neurol       Date:  2014-12-19       Impact factor: 4.849

4.  Vertical heterophoria and postural control in nonspecific chronic low back pain.

Authors:  Eric Matheron; Zoï Kapoula
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

5.  Cerebellum and ocular motor control.

Authors:  Amir Kheradmand; David S Zee
Journal:  Front Neurol       Date:  2011-09-01       Impact factor: 4.003

Review 6.  Vergence and Strabismus in Neurodegenerative Disorders.

Authors:  Sarah L Kang; Aasef G Shaikh; Fatema F Ghasia
Journal:  Front Neurol       Date:  2018-05-16       Impact factor: 4.003

7.  Influence of virtual reality on visual parameters: immersive versus non-immersive mode.

Authors:  Hyeon Jeong Yoon; Jonghwa Kim; Sang Woo Park; Hwan Heo
Journal:  BMC Ophthalmol       Date:  2020-05-24       Impact factor: 2.209

8.  Deficient vergence prism adaptation in subjects with decompensated heterophoria.

Authors:  Anna Przekoracka-Krawczyk; Krzysztof Piotr Michalak; Paulina Pyżalska
Journal:  PLoS One       Date:  2019-01-18       Impact factor: 3.240

9.  Effects of prolonged use of virtual reality smartphone-based head-mounted display on visual parameters: a randomised controlled trial.

Authors:  Hyeon Jeong Yoon; Hyun Sik Moon; Mi Sun Sung; Sang Woo Park; Hwan Heo
Journal:  Sci Rep       Date:  2021-07-28       Impact factor: 4.379

10.  Test-retest of a phoria adaptation stimulus-induced functional MRI experiment.

Authors:  Cristian Morales; Suril Gohel; Mitchell Scheiman; Xiaobo Li; Elio M Santos; Ayushi Sangoi; Tara L Alvarez
Journal:  J Vis       Date:  2020-08-03       Impact factor: 2.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.